Ep. 6: Ketamine in the Treatment of Mental Health Conditions: A Primer
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Ep. 6: Ketamine in the Treatment of Mental Health Conditions: A Primer
-
ナレーター：
-
著者：
概要
Led by ketamine experts Dr. Alexander Papp and Dr. Julie Myers, both faculty of Alliant's MSCP program, this episode of Psychopharmacology Today delves into the use of ketamine as a treatment for various mental health conditions, particularly depression and suicidal ideation. It explores the pharmacological mechanisms behind ketamine's rapid antidepressant effects, its clinical applications, and the importance of neuroplasticity in recovery. Drs. Papp and Myers highlight the growing acceptance of ketamine in clinical settings and the need for further research to optimize treatment protocols and understand long-term effects. They also address complexities of ketamine treatment, focusing on its side effects, practical applications, integration with therapy, best practices, and real-world case studies. Lastly, they emphasize the importance of understanding both the benefits and potential risks associated with ketamine, as well as the significance of proper administration and patient support throughout the treatment process.